Time to Ditch FDA Warning?
Older women using vaginal estrogen tablets do not face an increased risk for recurrent ischemic stroke, a finding…
Rivaroxaban or Combo Therapy: A Winner for All Ages? – Medscape
Rivaroxaban or Combo Therapy: A Winner for All Ages? MedscapeRivaroxaban Monotherapy Benefits Those with Atrial Fibrillation, Stable Coronary Artery…
PCPs Guide to Prescribing Blood Thinners for AF
As a primary care physician (PCP), you’re often the first healthcare professional that will identify cardiac issues, including…
Anticoagulants in AF Post-ICH: The Dilemma Continues
TOPLINE: In patients with atrial fibrillation (AF) with a recent episode of intracranial hemorrhage (ICH), the use of…